UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Blueprint Medicines Corp (BPMC)

Blueprint Medicines Corp (BPMC)
32.34 x 2 128.01 x 1
Pre-market by (Cboe BZX)
80.84 +0.57 (+0.71%) 04/11/25 [NASDAQ]
32.34 x 2 128.01 x 1
Pre-market 80.84 unch (unch) 16:00 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
77.63
Day High
81.28
Open 78.50
Previous Close 80.27 80.27
Volume 1,646,600 1,646,600
Avg Vol 1,210,810 1,210,810
Stochastic %K 35.24% 35.24%
Weighted Alpha -20.74 -20.74
5-Day Change -0.84 (-1.03%) -0.84 (-1.03%)
52-Week Range 73.04 - 121.90 73.04 - 121.90
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,166,160
  • Shares Outstanding, K 63,906
  • Annual Sales, $ 508,820 K
  • Annual Income, $ -67,090 K
  • EBIT $ -212 M
  • EBITDA $ -218 M
  • 60-Month Beta 0.75
  • Price/Sales 10.08
  • Price/Cash Flow N/A
  • Price/Book 17.07

Options Overview Details

View History
  • Implied Volatility 68.48% ( +2.55%)
  • Historical Volatility 45.98%
  • IV Percentile 97%
  • IV Rank 91.17%
  • IV High 71.56% on 02/11/25
  • IV Low 36.63% on 08/23/24
  • Put/Call Vol Ratio 0.07
  • Today's Volume 16
  • Volume Avg (30-Day) 1,105
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 30,932
  • Open Int (30-Day) 32,562

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.41
  • Number of Estimates 9
  • High Estimate 0.51
  • Low Estimate -0.77
  • Prior Year -1.32
  • Growth Rate Est. (year over year) +68.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.04 +10.68%
on 04/09/25
Period Open: 87.76
96.02 -15.81%
on 03/24/25
-6.92 (-7.89%)
since 03/11/25
3-Month
73.04 +10.68%
on 04/09/25
Period Open: 87.43
118.25 -31.64%
on 01/27/25
-6.59 (-7.54%)
since 01/10/25
52-Week
73.04 +10.68%
on 04/09/25
Period Open: 92.25
121.90 -33.68%
on 07/16/24
-11.41 (-12.37%)
since 04/11/24

Most Recent Stories

More News
Blueprint Medicines: Q4 Earnings Snapshot

Blueprint Medicines: Q4 Earnings Snapshot

BPMC : 80.84 (+0.71%)
Blueprint Stock Soars 18% on Encouraging 2025 Growth Strategy

Shares of Blueprint Medicines BPMC rallied 18.2% on Monday driven by investor enthusiasm following the company’s announcement of its 2025 corporate outlook and growth strategy, highlighting plans to...

CTMX : 0.5325 (+7.66%)
CSTL : 19.70 (+2.07%)
BPMC : 80.84 (+0.71%)
HALO : 60.22 (+4.37%)
Insider Sale: PRINCIPAL ACCOUNTING OFFICER of $BPMC (BPMC) Sells 1,200 Shares

Ariel Hurley, the PRINCIPAL ACCOUNTING OFFICER of $BPMC ($BPMC), sold 1,200 shares of the company on 12-12-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately...

BPMC : 80.84 (+0.71%)
Insider Sale: CHIEF OPERATING OFFICER of $BPMC (BPMC) Sells 2,274 Shares

Christina Rossi, the CHIEF OPERATING OFFICER of $BPMC ($BPMC), sold 2,274 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.1%...

BPMC : 80.84 (+0.71%)
Blueprint Medicines: Q3 Earnings Snapshot

Blueprint Medicines: Q3 Earnings Snapshot

BPMC : 80.84 (+0.71%)
Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

For Immediate ReleaseChicago, IL – October 25, 2024 – Today, Zacks Equity Research discusses Exelixis, Inc, EXEL, Blueprint Medicines BPMC, CRISPR Therapeutics CRSP, Amicus Therapeutics FOLD and Verona...

FOLD : 6.48 (-0.46%)
CRSP : 39.30 (+14.71%)
VRNA : 57.71 (+7.01%)
EXEL : 35.31 (+2.47%)
BPMC : 80.84 (+0.71%)
5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most major...

FOLD : 6.48 (-0.46%)
CRSP : 39.30 (+14.71%)
VRNA : 57.71 (+7.01%)
EXEL : 35.31 (+2.47%)
BPMC : 80.84 (+0.71%)
Blueprint Medicines: Q2 Earnings Snapshot

Blueprint Medicines: Q2 Earnings Snapshot

BPMC : 80.84 (+0.71%)
Blueprint Medicines: Q1 Earnings Snapshot

Blueprint Medicines: Q1 Earnings Snapshot

BPMC : 80.84 (+0.71%)
Blueprint Medicines: Q4 Earnings Snapshot

Blueprint Medicines: Q4 Earnings Snapshot

BPMC : 80.84 (+0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Blueprint Medicines Corporation is a biopharmaceutical company focused on developing the potentially transformational precision medicines to address patients with genomically defined cancers and rare diseases.

See More

Key Turning Points

3rd Resistance Point 85.85
2nd Resistance Point 83.56
1st Resistance Point 82.20
Last Price 80.84
1st Support Level 78.55
2nd Support Level 76.27
3rd Support Level 74.91

See More

52-Week High 121.90
Fibonacci 61.8% 103.24
Fibonacci 50% 97.47
Fibonacci 38.2% 91.70
Last Price 80.84
52-Week Low 73.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar